MENUMENU
  • Covid Clear
  • About Us
        • About Us

          An industry leading services provider in viral challenge studies and laboratory services supporting product development for customers developing antivirals, vaccines and respiratory therapeutics.

          • More about hVIVO
        • Overview
        • Executive Leadership Team
        • Scientific Papers / Abstracts
        • Quality Commitment
        • Ethics & Compliance
        • FluCamp
        • Human Challenge Programme
        • Challenge Agent Consortium
        • PrEP Biopharm Ltd
        • Imutex Ltd.
  • Services
        • Human challenge full-service solution
        • human challenge full service solution

          Industry leading provider of viral challenge studies

          • See Our Solution
        • hVIVO Challenge Models
          • Influenza
          • RSV
          • HRV
          • Asthma
          • COPD
          • Cough
        • Laboratory Services
          • Virology
          • Immunology
          • Biomarkers
          • Disease in Motion®
  • News, Media & Events
        • News, Media & Events

          A source for the latest press releases, scientific publications and other media as well as details of investor and scientific events that we attend and host across the world.

        • News & Media
        • Media Coverage
        • Company News
        • Media Press Kit
        • Videos
        • Events
        • img

          LATEST PRESS RELEASE

          13.04.21 Potential demerger of certain non-core assets
        • UPCOMING EVENTS

          London South East Webinar

          Tuesday 6th April

  • Volunteers
  • Careers
  • Contact Us

Categories for Blog

The “History” of the Flu Vaccine From 1940 to 2030?

Australian Flu Hits the Northern Hemisphere.

Here comes the flu.

Why do we need a cure for the common cold?

Man Flu: “I told you I was ill”

The Spread of Zika virus

Germany Confirms Five Zika Virus Cases

WHO leader: Zika virus ‘spreading explosively’

Beware Influenza, The Silent Killer – Forbes

China reports human H7N9 avian influenza infection in Shanghai man | Outbreak News Today

1 2 3 … 28 Next »
1 2 3 … 28 Next »

Whether you’re a potential customer, job seeker, health professional or an investor, you can find the best way to contact us from the list below.

Contact Us
  • Terms & Conditions
  • Careers
  • Sitemap
© 2021 Copyright hVIVO Services Limited. All rights reserved. hVIVO Services Limited (“hVIVO”) is registered in England and Wales with registration number 02326557 and registered office at Queen Mary BioEnterprises Innovation Centre, 42 New Road, London, E1 2AX, UK.
Privacy Policy | Cookie Policy